In one paragraphSynthesis in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Rafaela F RossettoSystematic Reviews Center for Cardiovascular and Metabolic Health, School of Philosophy and Sciences, São Paulo State University (UNESP), Av. HyginoMuzzi Filho, 737, Marília 17525-900, SP, Brazil.
Julia S PissocaroSystematic Reviews Center for Cardiovascular and Metabolic Health, School of Philosophy and Sciences, São Paulo State University (UNESP), Av. HyginoMuzzi Filho, 737, Marília 17525-900, SP, Brazil.
Davi A CavalheriSystematic Reviews Center for Cardiovascular and Metabolic Health, School of Philosophy and Sciences, São Paulo State University (UNESP), Av. HyginoMuzzi Filho, 737, Marília 17525-900, SP, Brazil.ORCID 0000-0003-2891-5600 Rodrigo D RaimundoLaboratório de Delineamento de Estudos e Escrita Científica, Centro Universitário, Faculdade de Medicina do ABC (FMABC), Santo André 09060-870, SP, Brazil.ORCID 0000-0002-3043-0728 Sandra Maria BarbalhoDepartment of Biochemistry and Pharmacology, School of Medicine, Universidade de Marília (UNIMAR), Marília 17525-902, SP, Brazil.ORCID 0000-0002-5035-876X Andrey A PortoDepartment of Pharmacology, School of Medicine of Ribeirao Preto, Faculdade de Medicina de Ribeirão Preto/Universidade de São Paulo-FMRP/USP, Ribeirao Preto 14049-900, SP, Brazil.ORCID 0000-0003-1097-5285 David M GarnerCardiorespiratory Research Group, School of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Headington Campus, Gipsy Lane, Oxford OX3 0BP, UK.ORCID 0000-0002-8114-9055 Vitor E ValentiSystematic Reviews Center for Cardiovascular and Metabolic Health, School of Philosophy and Sciences, São Paulo State University (UNESP), Av. HyginoMuzzi Filho, 737, Marília 17525-900, SP, Brazil.ORCID 0000-0001-7477-3805 Funding
Conselho Nacional de Desenvolvimento Científico e Tecnológico 302574/2021-2
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antidepressive AgentsCytokinesDepressive DisorderSertralineDouble-Blind MethodHumansInflammationInterleukin-10Randomized Controlled Trials as TopicSelective Serotonin Reuptake InhibitorsTumor Necrosis Factor-alphaAntidepressive AgentsCytokinesInterleukin-10Selective Serotonin Reuptake InhibitorsSertralineTumor Necrosis Factor-alphacytokinesdepressioninflammationmeta-analysissertraline
Identifiers
PMID42646594
PMCPMC13515890
What OpenQuestion holds
Textmetadata
Read underepoch 390